account_balance
Investment manager · 13F filer · SEC CIK 1792126
Logos Global Management LP
Reported value$2.32Bas of Jun 30, 2026
Positions68 25 new, 20 sold out
Top 10 weight48.3%ERAS alone is 10%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
ERASErasca Inc
9.6%Added +9%
ABVXAbivax SA
5.9%Added +52%
RVMDRevolution Medicines Inc
5.6%Trimmed −65%
IDYAIdeaya Biosciences Inc
4.8%Trimmed −13%
BNTXBiontech Se
4.1%New
VERAVera Therapeutics Inc
4.1%New
TNGXTango Therapeutics Inc
3.8%Trimmed −5%
PRAXPraxis Precision Medicines I
3.7%Trimmed −9%
CLDXCelldex Therapeutics Inc New
3.4%Added +367%
DNTHDianthus Therapeutics Inc
3.4%Added +100%
CGONCg Oncology Inc
3.1%Added +74%
IRONDisc Medicine Inc
2.8%Added +56%
ERASErasca Inc
9.6%Added +9%
ABVXAbivax SA
5.9%Added +52%
RVMDRevolution Medicines Inc
5.6%Trimmed −65%
IDYAIdeaya Biosciences Inc
4.8%Trimmed −13%
BNTXBiontech Se
4.1%New
VERA4.1%TNGX3.8%PRAX3.7%CLDX3.4%DNTH3.4%CGON3.1%IRON2.8%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
ERAS Erasca Inc 9.6% Added +9%ABVX Abivax SA 5.9% Added +52%RVMD Revolution Medicines Inc 5.6% Trimmed −65%IDYA Ideaya Biosciences Inc 4.8% Trimmed −13%BNTX Biontech Se 4.1% NewVERA Vera Therapeutics Inc 4.1% NewTNGX Tango Therapeutics Inc 3.8% Trimmed −5%PRAX Praxis Precision Medicines I 3.7% Trimmed −9%CLDX Celldex Therapeutics Inc New 3.4% Added +367%DNTH Dianthus Therapeutics Inc 3.4% Added +100%CGON Cg Oncology Inc 3.1% Added +74%IRON Disc Medicine Inc 2.8% Added +56%
What changed